Citation Impact
Citing Papers
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
European trends in breast cancer mortality, 1980–2017 and predictions to 2025
2021
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
MEK in cancer and cancer therapy
2013
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
RAS-targeted therapies: is the undruggable drugged?
2020
Lung cancer: current therapies and new targeted treatments
2016 Standout
Targeting multidrug resistance in cancer
2006 Standout
Body Image of Women with Breast Cancer After Mastectomy: A Qualitative Research
2016 Standout
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
2012
Nanoliposomal irinotecan plus fluorouracil and folinic acid: a new treatment option in metastatic pancreatic cancer
2016
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
2013
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies
2014
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Prospects for MEK inhibitors for treating cancer
2014
Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma
2000
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
Effect of time interval from diagnosis to treatment for cervical cancer on survival: A nationwide cohort study
2019
Tumour stem cells and drug resistance
2005 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Improving Prospects for Targeting RAS
2015
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Works of Constanta Timcheva being referenced
Does Verapamil Help Overcome Multidrug Resistance in Tumor Cell Lines and Cancer Patients?
1996
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
2011
Delays in diagnosis and treatment of breast cancer: a multinational analysis
2013
Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey.
2012